These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10413305)

  • 1. Differential interactions of nitric oxide donors with rat oxyhemoglobin.
    Tabrizi-Fard MA; Lee WI; Fung HL
    Biochem Pharmacol; 1999 Aug; 58(4):671-4. PubMed ID: 10413305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Don't just say no: Differential pathways and pharmacological responses to diverse nitric oxide donors.
    Chiesa JJ; Baidanoff FM; Golombek DA
    Biochem Pharmacol; 2018 Oct; 156():1-9. PubMed ID: 30080991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of nitrovasodilator bioactivation.
    Noack E; Feelisch M
    Basic Res Cardiol; 1991; 86 Suppl 2():37-50. PubMed ID: 1683227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide effect on the hemoglobin-oxygen affinity.
    Stepuro TL; Zinchuk VV
    J Physiol Pharmacol; 2006 Mar; 57(1):29-38. PubMed ID: 16601313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo.
    Rössig L; Fichtlscherer B; Breitschopf K; Haendeler J; Zeiher AM; Mülsch A; Dimmeler S
    J Biol Chem; 1999 Mar; 274(11):6823-6. PubMed ID: 10066732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various nitric oxide donors protect chick embryonic neurons from cyanide-induced apoptosis.
    Jensen MS; Nyborg NC; Thomsen ES
    Toxicol Sci; 2000 Nov; 58(1):127-34. PubMed ID: 11053549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction.
    Bizzozero OA; DeJesus G; Howard TA
    Neurochem Res; 2004 Sep; 29(9):1675-85. PubMed ID: 15453262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-Nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo.
    Katsumi H; Nishikawa M; Yamashita F; Hashida M
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1117-24. PubMed ID: 15901798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of nitric oxide donors in pharmacological studies.
    Feelisch M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jul; 358(1):113-22. PubMed ID: 9721012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress enhances and modulates protein S-nitrosation in smooth muscle cells exposed to S-nitrosoglutathione.
    Belcastro E; Wu W; Fries-Raeth I; Corti A; Pompella A; Leroy P; Lartaud I; Gaucher C
    Nitric Oxide; 2017 Sep; 69():10-21. PubMed ID: 28743484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Nitroso products from the reaction of indoles with Angeli's salt.
    Peyrot F; Fernandez BO; Bryan NS; Feelisch M; Ducrocq C
    Chem Res Toxicol; 2006 Jan; 19(1):58-67. PubMed ID: 16411657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production.
    Jaroszewski JJ; Bogacki M; Skarzynski DJ
    Reproduction; 2003 Mar; 125(3):389-95. PubMed ID: 12611602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratablet S-nitrosation: A New Approach for the Oral Administration of S-nitrosothiols as Nitric Oxide Donors.
    de Souza GF; de Oliveira MG
    J Pharm Sci; 2016 Jan; 105(1):359-61. PubMed ID: 26852866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
    Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
    J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
    Tseng CM; Tabrizi-Fard MA; Fung HL
    J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1 alpha protein as a target for S-nitrosation.
    Sumbayev VV; Budde A; Zhou J; Brüne B
    FEBS Lett; 2003 Jan; 535(1-3):106-12. PubMed ID: 12560087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a hemoglobin-trapping approach in the determination of nitric oxide in in vitro and in vivo systems.
    Balcioglu A; Watkins CJ; Maher TJ
    Neurochem Res; 1998 May; 23(5):815-20. PubMed ID: 9566622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics.
    Artz JD; Toader V; Zavorin SI; Bennett BM; Thatcher GR
    Biochemistry; 2001 Aug; 40(31):9256-64. PubMed ID: 11478893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.
    Müller-Strahl G; Kottenberg K; Zimmer HG; Noack E; Kojda G
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):311-20. PubMed ID: 10639106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.